Amyotrophic lateral sclerosis (ALS), often referred to as "Lou Gehrig's Disease," is a rare, progressive neurodegenerative disease that affects nerve cells in the human brain and the spinal cord. This motor neuron disease causes atrophy of muscles and weakness, muscle spams, speech disabilities, pathology of reflexes, depressive states, respiratory difficulties, unbalancing, spasticity, fibrillation, atrophy and other debilitating and weaking conditions that might last 2-5 years with fatal outcome in all cases.

The latest stem cell research geared towards the rapid regeneration of cells affected by the ALS disease is having enormous impact and promising results for many ALS patients worldwide. Regenobody stem cell clinic is actively working with some of the most advanced clinical stem cell types in order to achieve the best results when treating ALS with stem cells transplants. The cells adapt and regenerate lost ones with new ones from the same person. In some instances, stem cells that are defined as allegeneic are used to treat patients with various conditions such as ALS. The difference between autologous and allegeneic stem cells is that the former come from your own body, while the latter comes from donors.  It is important that the transplant physicians and stem cell laboratory technicians are experienced staff in such a new field, we at Regenobody employ the qualified, experienced staff to work with our patients. A stem cell treatment clinic based in the USA might have a lot of problems to treat ALS with stem cells because of federal and local regulations, this is one reason why our treatment clinic is located in the beautiful Caribbean island of the Dominican Republic.

Transplanting stem cells to ALS patients have resulted in a diminished sense of weakness, improvement of speech, appetite, better swallowing and general well being. While stem cell treatment of ALS does not attack the main cause of the disease, it does slow down the progress of it. Not every patients responds in the same way to treatment, and about half of the patients need to have the process repeated within the first year to retain the good results and extend their lives.

Stem cell treatment has become the latest weapon against the progression of Amyotrophic lateral sclerosis, and as time goes by, new studies will ensure that a larger number of patients benefit from the stemcell treatment.